Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Receivables - Other (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Receivables - Other over the past 15 years, most recently at $7.0 million for Q2 2025.

  • For Q2 2025, Receivables - Other rose 71.52% year-over-year to $7.0 million; the TTM value through May 2025 reached $7.0 million, up 71.52%, while the annual FY2025 figure was $7.0 million, 71.52% up from the prior year.
  • Receivables - Other for Q2 2025 was $7.0 million at Lifecore Biomedical, Inc. \De\, up from $6.1 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $13.9 million in Q1 2022 and troughed at $200000.0 in Q1 2021.
  • A 5-year average of $6.7 million and a median of $5.7 million in 2024 define the central range for Receivables - Other.
  • Biggest five-year swings in Receivables - Other: plummeted 98.15% in 2021 and later soared 6850.0% in 2022.
  • Year by year, Receivables - Other stood at $12.6 million in 2021, then crashed by 33.33% to $8.4 million in 2022, then crashed by 65.48% to $2.9 million in 2023, then soared by 96.48% to $5.7 million in 2024, then rose by 22.48% to $7.0 million in 2025.
  • Business Quant data shows Receivables - Other for LFCR at $7.0 million in Q2 2025, $6.1 million in Q1 2025, and $5.7 million in Q4 2024.